MedPath

SAITAMA MEDICAL UNIVERSITY INTERNATIONAL MEDICAL CENTER

🇯🇵Japan
Ownership
Private
Established
2007-01-01
Employees
-
Market Cap
-
Website
http://www.international.saitama-med.ac.jp

Clinical Trials

87

Active:0
Completed:43

Trial Phases

3 Phases

Phase 2:6
Phase 4:1
Not Applicable:80

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (87 trials with phase data)• Click on a phase to view related trials

Not Applicable
80 (92.0%)
Phase 2
6 (6.9%)
Phase 4
1 (1.1%)

Pembrolizumab Plus Olaparib in Patients With Recurrent Cervical Cancer

Phase 2
Conditions
Cervical Cancer
Interventions
First Posted Date
2020-11-24
Last Posted Date
2022-08-09
Lead Sponsor
Saitama Medical University International Medical Center
Target Recruit Count
28
Registration Number
NCT04641728
Locations
🇯🇵

Saitama Medical Uiversity International Medical Center, Hidaka, Saitama, Japan

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.